Buscar en RiuNet

Listar

Mostrando ítems 1-3 de 3

A coordinated control strategy for insulin and glucagon delivery in type 1 diabetes

Herrero, P.; Bondía Company, Jorge; Oliver, N.; Georgiou, P. (Taylor & Francis, 2017)

[EN] Type 1 diabetes is an autoimmune condition characterised by a pancreatic insulin secretion deficit, resulting in high blood glucose concentrations, which can lead to micro- and macrovascular complications. Type 1 ...
Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target

Rossetti, P.; Quirós, C.; Moscardo-Garcia, Vanessa; Comas, A.; Giménez, M.; Ampudia-Blasco, F.J.; León, F.; Montaser Roushdi Ali, Eslam; Conget, I.; Bondía Company, Jorge; Vehí, J. (Mary Ann Liebert, 2017-06)

[EN] Background: Postprandial (PP) control remains a challenge for closed-loop (CL) systems. Few studies with inconsistent results have systematically investigated the PP period. Objective: To compare a new CL algorithm ...
Safety Auxiliary Feedback Element for the Artificial Pancreas in Type 1 Diabetes

Revert Tomás, Ana; Garelli, Fabricio; Picó, Jesús; De Battista, Hernan; Rossetti, Paolo; Bondía Company, Jorge (Institute of Electrical and Electronics Engineers, 2013-08)

[EN] The artificial pancreas aims at the automatic deliv-ery of insulin for glycemic control in patients with type 1 diabetes, i.e., closed-loop glucose control. One of the challenges of the arti-ficial pancreas is to avoid ...

Mostrando ítems 1-3 de 3